I8S.F INTRASENSE SAS EO -05

Healthcare Health Care Technology Frankfurt Exchange
0.1790 EUR
Close of Nov 12, 2026
0.1590 0.3840
Market cap
EUR 9.44M
P/E
-
P/B
2.03x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is I8S.F undervalued?

Graham number

The Graham number of INTRASENSE SAS EO -05 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

INTRASENSE SAS EO -05 fundamental analysis

No fundamental analysis for INTRASENSE SAS EO -05 yet.

INTRASENSE SAS EO -05 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About INTRASENSE SAS EO -05

Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was in…

Full company profile